HomeTherapeutic areasMetabolic › Severe Primary IGF-1 Deficiency

Severe Primary IGF-1 Deficiency (1 companies)

Companies with an active program in Severe Primary IGF-1 Deficiency.

Ticker Company Therapeutic areas Programs Lead stage Programs
ETON Eton Pharmaceuticals, Inc. GI/HepatologyMetabolicRenal Rare 1 Approved 14